Future Financial Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-65
Closed -$9.11K – 151
2025
Q3
$9.11K Hold
65
– – 0.01% 387
2025
Q2
$8.16K Hold
65
– – 0.01% 381
2025
Q1
$8.89K Hold
65
– – 0.01% 377
2024
Q4
$9.94K Hold
65
– – 0.01% 369
2024
Q3
$12.6K Buy
+65
New +$13.6K 0.01% 372
2024
Q2
– Sell
-65
Closed -$14K – 148
2024
Q1
$14K Buy
+65
New +$15.2K 0.01% 380
2022
Q2
– Sell
-65
Closed -$14K – 158
2022
Q1
$14K Sell
65
-100
-61% -$21.7K 0.01% 396
2021
Q4
$40K Buy
+165
New +$42.4K 0.03% 302

Other funds holding BIIB

Future Financial Wealth Management's BIIB Position: Q4 2025 in Review

Future Financial Wealth Management sold out of Biogen (BIIB) in Q4 2025, closing a stake of 65 shares — an estimated $9.11K sold.

Future Financial Wealth Management first reported a position in BIIB in Q4 2021 and held it in 8 quarters. The position peaked at $40K in Q4 2021. 1,000 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

  • Future Financial Wealth Management reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
  • Future Financial Wealth Management sold 65 Biogen shares in Q4 2025, an estimated $9.11K.
  • Future Financial Wealth Management first reported a position in Biogen in Q4 2021 and held it in 8 quarters.
  • Future Financial Wealth Management's Biogen position peaked at $40K in Q4 2021.
  • 1,000 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on Future Financial Wealth Management's 13F filing for Q4 2025, filed 21 Jan 2026.